Reports for ALPROLIX
Brand name
ALPROLIX
Company Name
SANOFI-AVENTIS CANADA INC
|
Drug Identification Number
02422956 |
Ingredients
RECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN |
Ingredient Strength
3000 UNIT |
ATC Code
B02BD |
ATC Descriptor
VITAMIN K AND OTHER HEMOSTATICS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| ALPROLIX | 1 | Resolved | 2023-05-15 | 2023-06-21 | 192507 |
| ALPROLIX | 1 VIAL & 5 ML PREFILLED DILUENT SYRINGE | Resolved | 2022-08-16 | 2022-10-12 | 166860 |
| ALPROLIX | 3000 IU/vial | Resolved | 2023-01-06 | 2023-01-31 | 180122 |
| ALPROLIX | 3000 IU/vial | Resolved | 2023-06-29 | 2023-07-10 | 196825 |
Showing 1 to 4 of 4
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0